1. Home
  2. INLX vs HBIO Comparison

INLX vs HBIO Comparison

Compare INLX & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

HOLD

Current Price

$8.25

Market Cap

40.8M

Sector

Technology

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$0.70

Market Cap

33.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
INLX
HBIO
Founded
1996
1901
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
40.8M
33.8M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
INLX
HBIO
Price
$8.25
$0.70
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$2.50
AVG Volume (30 Days)
2.6K
1.0M
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,539,674.00
$87,371,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$15.82
$7.22
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.37
$0.28
52 Week High
$15.72
$2.36

Technical Indicators

Market Signals
Indicator
INLX
HBIO
Relative Strength Index (RSI) 31.87 53.48
Support Level $8.40 $0.71
Resistance Level $8.53 $0.78
Average True Range (ATR) 0.12 0.07
MACD 0.05 -0.01
Stochastic Oscillator 10.48 34.72

Price Performance

Historical Comparison
INLX
HBIO

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: